Cardiome Pharma Corporation (CRME)
Add to Watchlists Create an Alert
2.00
-0.02 -0.99%
NASDAQ
May 22, 8:00PM
BATS Real time
Currency in USD
Cardiome Pharma Corporation SG&A Expense Quarterly:
2.356M for Dec. 31, 2012Cardiome Pharma Corporation Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 2.356M |
| Sept. 30, 2012 | 2.496M |
| June 30, 2012 | 2.21M |
| March 31, 2012 | 2.739M |
| Dec. 31, 2011 | 2.095M |
| Sept. 30, 2011 | 2.764M |
| June 30, 2011 | 3.466M |
| March 31, 2011 | 3.224M |
| Dec. 31, 2010 | 2.74M |
| Sept. 30, 2010 | 3.505M |
| June 30, 2010 | 3.272M |
| March 31, 2010 | 3.358M |
| Dec. 31, 2009 | 3.367M |
| Sept. 30, 2009 | 4.193M |
| June 30, 2009 | 4.226M |
| March 31, 2009 | 3.32M |
| Dec. 31, 2008 | 1.510M |
| Sept. 30, 2008 | 4.552M |
| June 30, 2008 | 4.329M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Aug. 31, 2003 | Go Pro |
| May 31, 2003 | Go Pro |
| Feb. 28, 2003 | Go Pro |
| Nov. 30, 2002 | Go Pro |
| Aug. 31, 2002 | Go Pro |
| May 31, 2002 | Go Pro |
| Feb. 28, 2002 | Go Pro |
| Nov. 30, 2001 | Go Pro |
| Aug. 31, 2001 | Go Pro |
| May 31, 2001 | Go Pro |
| Feb. 28, 2001 | Go Pro |
| Nov. 30, 2000 | Go Pro |
| Aug. 31, 2000 | Go Pro |
| May 31, 2000 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
CRME SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Merrimack Pharmaceuticals | 4.155M |
| Chemocentryx | 2.826M |
| QLT | 2.082M |
CRME SG&A Expense Quarterly Rankings
| Overall |
48th percentile 4115 of 8006 |
| Sector |
35th percentile 440 of 686 in Healthcare |
| Industry |
44th percentile 137 of 248 in Biotechnology |
CRME SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 1.510M | Dec 2008 |
| Maximum | 4.552M | Sep 2008 |
| Average | 3.143M |
CRME News
Cardiome Pharma Management Discusses Q1 2013 Results - Earnings Call Transcript
Seeking Alpha May 13
Seeking Alpha May 13